You are here

AusPAR: Dapagliflozin

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

21 April 2021
AusPAR Details
AusPAR
Active Ingredient
Dapagliflozin
Product Name
Forxiga
Sponsor
AstraZeneca Pty Ltd
Submission Number
PM-2019-05370-1-3
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
6 April 2021
Publication Date

21 April 2021